PNC Financial Services Group’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $504K | Buy |
27,698
+4,373
| +19% | +$79.6K | ﹤0.01% | 1551 |
|
|
2025
Q1 | $463K | Buy |
23,325
+4,553
| +24% | +$90.3K | ﹤0.01% | 1572 |
|
|
2024
Q4 | $322K | Buy |
18,772
+2,279
| +14% | +$39.1K | ﹤0.01% | 1857 |
|
|
2024
Q3 | $330K | Buy |
16,493
+16,364
| +12,685% | +$327K | ﹤0.01% | 1832 |
|
|
2024
Q2 | $1.44K | Buy |
129
+95
| +279% | +$1.06K | ﹤0.01% | 4343 |
|
|
2024
Q1 | $224 | Buy |
34
+9
| +36% | +$59 | ﹤0.01% | 4597 |
|
|
2023
Q4 | $113 | Buy |
+25
| New | +$113 | ﹤0.01% | 4514 |
|
|
2021
Q3 | – | Sell |
-1,600
| Closed | -$2K | – | 4280 |
|
|
2021
Q2 | $2K | Buy |
+1,600
| New | +$2K | ﹤0.01% | 4011 |
|